Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd029ecfe6cc0568f6d625dcc4912e30 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-805 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-8117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-0216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-922 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-8164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
filingDate |
2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ca8fecde15600442e29a4e5f41929d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c9f6d78239dbeaa5f8e348937d92379 |
publicationDate |
2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2678944-T3 |
titleOfInvention |
Compositions to prevent or treat allergic skin disorders, which contain GPCR19 agents as active ingredients |
abstract |
Receptor 19 agonist coupled to G protein (GPCR19) in an antiallergic amount effective for use as a medicine in the prophylactic or therapeutic treatment of allergic skin diseases, in which the GPCR19 agonist is sodium taurodeoxycholate. |
priorityDate |
2013-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |